{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:33:30Z","timestamp":1789774410995,"version":"4.0.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T00:00:00Z","timestamp":1366761600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0062175","type":"journal-article","created":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T21:13:03Z","timestamp":1366837983000},"page":"e62175","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Epidermal Growth Factor Receptor (EGFR)-RAS Signaling Pathway in Penile Squamous Cell Carcinoma"],"prefix":"10.1371","volume":"8","author":[{"given":"Hong-Feng","family":"Gou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Tao","family":"Men","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Mei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1136\/bmj.311.7018.1471","article-title":"Falling incidence of penis cancer in an uncircumcised population (Denmark 1943\u201390)","volume":"311","author":"M Frisch","year":"1995","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ju.0000062829.43654.5e","article-title":"Advanced penile carcinoma","volume":"170","author":"DJ Culkin","year":"2003","journal-title":"J Urol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.eururo.2011.08.028","article-title":"Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study","volume":"60","author":"G Di Lorenzo","year":"2011","journal-title":"Eur Urol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-3284-2-8","article-title":"Molecular targeted therapies in head and neck cancer \u2013 an update of recent developments","volume":"2","author":"M Goerner","year":"2010","journal-title":"Head Neck Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijrobp.2003.11.041","article-title":"Review of epidermal growth factor receptor biology","volume":"59","author":"RS Herbst","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.currproblcancer.2009.10.002","article-title":"Epidermal growth factor receptor inhibitors: current status and future directions","volume":"33","author":"HX Chen","year":"2009","journal-title":"Curr Probl Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"JA Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","article-title":"KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer","volume":"66","author":"A Lievre","year":"2006","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4161\/cbt.10.7.12793","article-title":"Nimotuzumab with chemoradiation confers a survival advantage in treatment-naive head and neck tumors over expressing EGFR","volume":"10","author":"C Basavaraj","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","article-title":"Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer","volume":"360","author":"E Van Cutsem","year":"2009","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"H Davies","year":"2002","journal-title":"Nature"},{"key":"ref12","first-page":"6206","article-title":"Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer","volume":"63","author":"DH Kim","year":"2003","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/77083","article-title":"Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3","volume":"25","author":"R Dammann","year":"2000","journal-title":"Nat Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"35669","DOI":"10.1074\/jbc.C000463200","article-title":"Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis","volume":"275","author":"MD Vos","year":"2000","journal-title":"J Biol Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/sj.onc.1205192","article-title":"The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1","volume":"21","author":"S Ortiz-Vega","year":"2002","journal-title":"Oncogene"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1309\/X4UADHVN317V2XMW","article-title":"Epidermal growth factor receptor expression in anal canal carcinoma","volume":"124","author":"LH Le","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1476-4598-6-49","article-title":"RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis","volume":"6","author":"I Peters","year":"2007","journal-title":"Mol Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1158\/1078-0432.CCR-09-2446","article-title":"Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases","volume":"16","author":"SE Baldus","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Carthon BC, Pettaway CA, Pagliaro LC (2010): <italic>e15022<\/italic> Epidermal growth factor receptor (EGFR) targeted therapy in advanced metastatic squamous cell carcinoma (AMSCC) of the penis: Updates and molecular analyses. <italic>ASCO MEETING ABSTRACTS<\/italic>.","DOI":"10.1200\/jco.2010.28.15_suppl.e15022"},{"key":"ref20","first-page":"1483","article-title":"[Characterization of the EGF receptor status in penile cancer: retrospective analysis of the course of the disease in 45 patients]","volume":"48","author":"C Borgermann","year":"2009","journal-title":"Urologe A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3747\/co.v17i1.471","article-title":"EGFR overexpression in squamous cell carcinoma of the penis","volume":"17","author":"N Lavens","year":"2010","journal-title":"Curr Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1200\/JCO.2006.07.2587","article-title":"Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas","volume":"24","author":"CH Chung","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1038\/sj.onc.1206705","article-title":"Mutations of the BRAF gene in squamous cell carcinoma of the head and neck","volume":"22","author":"A Weber","year":"2003","journal-title":"Oncogene"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.juro.2007.12.040","article-title":"PIK3CA, HRAS and KRAS gene mutations in human penile cancer","volume":"179","author":"P Andersson","year":"2008","journal-title":"J Urol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1200\/JCO.2011.35.9638","article-title":"Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations","volume":"29","author":"A Marchetti","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1200\/JCO.2010.33.5091","article-title":"Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status","volume":"29","author":"E Van Cutsem","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1155\/2007\/291538","article-title":"The role of RASSF1A methylation in cancer","volume":"23","author":"LB Hesson","year":"2007","journal-title":"Dis Markers"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1440-1827.2008.02259.x","article-title":"Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men","volume":"58","author":"N Yanagawa","year":"2008","journal-title":"Pathol Int"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1242\/jcs.010389","article-title":"The RASSF1A tumor suppressor","volume":"120","author":"H Donninger","year":"2007","journal-title":"J Cell Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1038\/sj.onc.1205466","article-title":"K-ras mutations and RASSF1A promoter methylation in colorectal cancer","volume":"21","author":"M van Engeland","year":"2002","journal-title":"Oncogene"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1038\/sj.onc.1204469","article-title":"The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas","volume":"20","author":"R Dammann","year":"2001","journal-title":"Oncogene"},{"key":"ref32","first-page":"131","article-title":"Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma","volume":"8","author":"J Kwong","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref33","first-page":"1888","article-title":"Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection","volume":"63","author":"I Kuzmin","year":"2003","journal-title":"Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e537","DOI":"10.1371\/journal.pone.0000537","article-title":"The isolation of nucleic acids from fixed, paraffin-embedded tissues-which methods are useful when?","volume":"2","author":"MT Gilbert","year":"2007","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0062175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T19:27:26Z","timestamp":1644866846000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0062175"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Viglietto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,24]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0062175","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,24]]}}}